| 2023-07-26 | Sale | McCormick & Company, Incorporated MKC | director | 5,000 0.0019% | $89.88 | $449,422 | -23.22% | |
| 2020-08-13 | Sale | McCormick & Company, Incorporated MKC | director | 10,000 0.0074% | $199.49 | $1.99M | -9.56% | |
| 2019-08-16 | Sale | McCormick & Company, Incorporated MKC | director | 5,000 0.0026% | $116.31 | $581,548 | -2.2% | |
| 2014-06-30 | McCormick & Company, Incorporated MKC | director | 1,000 0.0008% | $71.77 | $71,770 | +3.43% | ||
| 2014-01-31 | McCormick & Company, Incorporated MKC | director | 310 0.0002% | $64.40 | $19,963 | +10.78% | ||
| 2013-07-29 | Sale | Eli Lilly and Company LLY | SVP&Pres., Emerging Markets | 7,500 0.0007% | $53.74 | $403,050 | +2.69% | |
| 2013-01-30 | Sale | Eli Lilly and Company LLY | SVP&Pres., Emerging Markets | 15,000 0.0013% | $54.14 | $812,100 | -0.51% | |
| 2012-06-14 | Sale | Eli Lilly and Company LLY | SVP&Pres., Emerging Markets | 2,125 0.0002% | $41.60 | $88,400 | +22.28% | |
| 2012-05-14 | Sale | Eli Lilly and Company LLY | SVP&Pres., Emerging Markets | 2,000 0.0002% | $41.04 | $82,080 | +21.32% | |
| 2012-04-17 | Sale | Eli Lilly and Company LLY | SVP&Pres., Emerging Markets | 2,000 0.0002% | $40.00 | $80,000 | +22.42% | |
| 2012-03-12 | Sale | Eli Lilly and Company LLY | SVP&Pres., Emerging Markets | 2,000 0.0002% | $39.60 | $79,200 | +19.46% | |
| 2011-11-18 | Sale | Eli Lilly and Company LLY | SVP&Pres., Emerging Markets | 5,000 0.0004% | $36.88 | $184,400 | +13.74% | |
| 2011-03-04 | Sale | Eli Lilly and Company LLY | SVP&Pres., Emerging Markets | 5,000 0.0004% | $34.50 | $172,500 | +10.95% | |
| 2010-03-11 | Sale | Eli Lilly and Company LLY | SVP&Pres., Emerging Markets | 4,000 0.0004% | $35.41 | $141,625 | +1.06% | |
| 2010-02-17 | Sale | Eli Lilly and Company LLY | SVP&Pres., Emerging Markets | 2,000 0.0002% | $34.35 | $68,700 | +4.95% |